Telix Pharmaceuticals | TLX - 资产

股票价格
14.21
每天变化
-0.05 -0.35%
每月一次
-3.73%
每年
-43.94%
Q2 预测
14.44


金融业
股票价格
AUD
资产
AUD 1.16B
现金及等价物
AUD 207.16M
销售成本
AUD 221.36M
流动资产
AUD 330.28M
流动负债
AUD 231.62M
债务
AUD 418.25M
EBIT
AUD 8.04M
EBITDA
AUD 18.42M
EPS每股收益
AUD -0.05
股本和储备
AUD 416.86M
销售毛利
AUD 217.82M
债务利息支出
AUD 7.62M
利息收入
AUD 1.37M
贷款资金
AUD 448.45M
市值
AUD 4.62B
净收入
AUD -4.83M
营业费用
AUD 405.4M
营业利润
AUD 8.04M
普通股股本
AUD 338.78M
PE价格收益
244.46
税前利润
AUD 76.73M
销售收入
AUD 413.44M
销售和管理费用
AUD 93.48M
股票
AUD 35.23M
贸易债权人
AUD 71.66M
应收帐款人
AUD 135.25M


资产 更改 日
Cochlear AUD 2.79B 31.3M 2025-12
CSL USD 37.9B 1.5B 2025-12
Integral Diagnostics AUD 744.28M 1.52M 2024-06
Mayne Pharma AUD 1.14B 9.47M 2024-06
Medical Developments International AUD 63.57M 2.83M 2025-12
Mesoblast USD 782.31M 2.38M 2025-12
Neuren Pharmaceuticals AUD 342.86M 11.61M 2025-12
Pacific Edge NZD 34.66M 2.37M 2025-12
Paradigm Biopharmaceuticals AUD 23.15M 1.42M 2025-12
Polynovo AUD 123.37M 4.04M 2025-12
PYC Therapeutics AUD 159.13M 24.15M 2025-12
Ramsay Health Care AUD 21.7B 777.8M 2025-12
ResMed USD 8.5B 195.02M 2025-12
Sonic Healthcare AUD 15.38B 550.57M 2024-12